Sage Therapeutic Stock Technical Analysis
SAGE Stock | USD 13.04 0.47 3.74% |
As of the 19th of April, Sage Therapeutic has the Coefficient Of Variation of (375.53), variance of 13.85, and Risk Adjusted Performance of (0.16). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sage Therapeutic, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Sage Therapeutic, which can be compared to its competition. Please validate Sage Therapeutic standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Sage Therapeutic is priced more or less accurately, providing market reflects its prevalent price of 13.04 per share. Given that Sage Therapeutic has information ratio of (0.28), we advise you to double-check Sage Therapeutic's current market performance to make sure the company can sustain itself at a future point.
Sage Therapeutic Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sage, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SageSage |
Sage Therapeutic Analyst Consensus
Target Price | Advice | # of Analysts | |
25.71 | Buy | 21 | Odds |
Most Sage analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sage stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sage Therapeutic, talking to its executives and customers, or listening to Sage conference calls.
Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sage Therapeutic Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sage Therapeutic volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Sage Therapeutic Trend Analysis
Use this graph to draw trend lines for Sage Therapeutic. You can use it to identify possible trend reversals for Sage Therapeutic as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sage Therapeutic price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Sage Therapeutic Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Sage Therapeutic applied against its price change over selected period. The best fit line has a slop of 0.2 , which may suggest that Sage Therapeutic market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1535.96, which is the sum of squared deviations for the predicted Sage Therapeutic price change compared to its average price change.About Sage Therapeutic Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sage Therapeutic on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sage Therapeutic based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sage Therapeutic price pattern first instead of the macroeconomic environment surrounding Sage Therapeutic. By analyzing Sage Therapeutic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sage Therapeutic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sage Therapeutic specific price patterns or momentum indicators. Please read more on our technical analysis page.
2022 | 2023 | 2024 (projected) | Dividend Yield | 0.001427 | 0.001284 | 0.001238 | Price To Sales Ratio | 294.29 | 15.0 | 14.25 |
Sage Therapeutic April 19, 2024 Technical Indicators
Most technical analysis of Sage help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sage from various momentum indicators to cycle indicators. When you analyze Sage charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.16) | |||
Market Risk Adjusted Performance | (0.49) | |||
Mean Deviation | 2.4 | |||
Coefficient Of Variation | (375.53) | |||
Standard Deviation | 3.72 | |||
Variance | 13.85 | |||
Information Ratio | (0.28) | |||
Jensen Alpha | (1.12) | |||
Total Risk Alpha | (1.35) | |||
Treynor Ratio | (0.50) | |||
Maximum Drawdown | 31.44 | |||
Value At Risk | (4.75) | |||
Potential Upside | 2.82 | |||
Skewness | (1.47) | |||
Kurtosis | 10.39 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sage Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.Note that the Sage Therapeutic information on this page should be used as a complementary analysis to other Sage Therapeutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Sage Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.05) | Revenue Per Share 1.445 | Quarterly Revenue Growth 26.215 | Return On Assets (0.31) | Return On Equity (0.53) |
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.